{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:51:25Z","timestamp":1794012685083,"version":"4.8.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["21125"],"award-info":[{"award-number":["21125"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["21125"],"award-info":[{"award-number":["21125"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501034"],"award-info":[{"award-number":["81501034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771364"],"award-info":[{"award-number":["81771364"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771364"],"award-info":[{"award-number":["81771364"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Discov"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Myasthenia gravis (MG) is a rare autoimmune disease. Although the impact of immune cell disorder in MG has been extensively studied, little is known about the transcriptomes of individual cells. Here, we assessed the transcriptional profiles of 39,243 cells by single-cell sequencing and identified 13 major cell clusters, along with 39 subgroups of cells derived from patients with new-onset myasthenia gravis and healthy controls. We found that B cells, CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells, and monocytes exhibited more heterogeneity in MG patients. CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells were expanded in MG patients. We reclustered B cells and CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells, and predict their essential regulators. Further analyses demonstrated that B cells in MG exhibited higher transcriptional activity towards plasma cell differentiation, CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cell subsets were unbalanced, and inflammatory pathways of monocytes were highly activated. Notably, we discovered a disease-relevant subgroup, CD180\n                    <jats:sup>\u2212<\/jats:sup>\n                    B cells. Increased CD180\n                    <jats:sup>\u2212<\/jats:sup>\n                    B cells in MG are indicative of a high IgG composition and were associated with disease activity and the anti-AChR antibody. Together, our data further the understanding of the cellular heterogeneity involved in the pathogenesis of MG and provide large cell-type-specific markers for subsequent research.\n                  <\/jats:p>","DOI":"10.1038\/s41421-021-00314-w","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T13:02:51Z","timestamp":1631624571000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Single-cell RNA-Seq reveals transcriptional heterogeneity and immune subtypes associated with disease activity in human myasthenia gravis"],"prefix":"10.1038","volume":"7","author":[{"given":"Wanlin","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8164-2141","authenticated-orcid":false,"given":"Qi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengkai","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,14]]},"reference":[{"key":"314_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-10-46","volume":"10","author":"AS Carr","year":"2010","unstructured":"Carr, A. S., Cardwell, C. R., McCarron, P. O. & McConville, J. A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol. 10, 46 (2010).","journal-title":"BMC Neurol."},{"key":"314_CR2","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/BOR.0000000000000647","volume":"31","author":"R Mantegazza","year":"2019","unstructured":"Mantegazza, R. & Cavalcante, P. Diagnosis and treatment of myasthenia gravis. Curr. Opin. Rheumatol. 31, 623\u2013633 (2019).","journal-title":"Curr. Opin. Rheumatol."},{"key":"314_CR3","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","volume":"26","author":"JM Lindstrom","year":"1976","unstructured":"Lindstrom, J. M., Seybold, M. E., Lennon, V. A., Whittingham, S. & Duane, D. D. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 26, 1054\u20131059 (1976).","journal-title":"Neurology"},{"key":"314_CR4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.molimm.2008.08.274","volume":"46","author":"Y Zhang","year":"2009","unstructured":"Zhang, Y. et al. Dendritic cells transduced with lentiviral-mediated RelB-specific ShRNAs inhibit the development of experimental autoimmune myasthenia gravis. Mol. Immunol. 46, 657\u2013667 (2009).","journal-title":"Mol. Immunol."},{"key":"314_CR5","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1172\/JCI78084","volume":"125","author":"J Suurmond","year":"2015","unstructured":"Suurmond, J. & Diamond, B. Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity. J. Clin. Invest. 125, 2194\u20132202 (2015).","journal-title":"J. Clin. Invest."},{"key":"314_CR6","doi-asserted-by":"publisher","first-page":"175628561774913","DOI":"10.1177\/1756285617749134","volume":"11","author":"R Mantegazza","year":"2018","unstructured":"Mantegazza, R. & Antozzi, C. When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies. Ther. Adv. Neurol. Disord. 11, 1756285617749134 (2018).","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"314_CR7","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus, N. E. & Verschuuren, J. J. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 14, 1023\u20131036 (2015).","journal-title":"Lancet Neurol."},{"key":"314_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2019.11.014","volume":"52","author":"AR Cillo","year":"2020","unstructured":"Cillo, A. R. et al. Immune landscape of viral- and carcinogen-driven head and neck cancer. Immunity 52, 183\u2013199 (2020).","journal-title":"Immunity"},{"key":"314_CR9","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1038\/s41467-021-22300-2","volume":"12","author":"Q Hu","year":"2021","unstructured":"Hu, Q. et al. Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profiling. Nat Commun 12, 2186 (2021).","journal-title":"Nat Commun"},{"key":"314_CR10","doi-asserted-by":"crossref","unstructured":"King, H. W. et al. Single-cell analysis of human B cell maturation predicts how antibody class switching shapes selection dynamics. Sci Immunol 6 (2021).","DOI":"10.1126\/sciimmunol.abe6291"},{"key":"314_CR11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nri3795","volume":"15","author":"SL Nutt","year":"2015","unstructured":"Nutt, S. L., Hodgkin, P. D., Tarlinton, D. M. & Corcoran, L. M. The generation of antibody-secreting plasma cells. Nat. Rev. Immunol. 15, 160\u2013171 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"314_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.immuni.2006.02.003","volume":"24","author":"KP Nera","year":"2006","unstructured":"Nera, K. P. et al. Loss of Pax5 promotes plasma cell differentiation. Immunity 24, 283\u2013293 (2006).","journal-title":"Immunity"},{"key":"314_CR13","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.immuni.2009.10.008","volume":"31","author":"H Kwon","year":"2009","unstructured":"Kwon, H. et al. Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors. Immunity 31, 941\u2013952 (2009).","journal-title":"Immunity"},{"key":"314_CR14","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/383538a0","volume":"383","author":"DB Schubart","year":"1996","unstructured":"Schubart, D. B., Rolink, A., Kosco-Vilbois, M. H., Botteri, F. & Matthias, P. B-cell-specific coactivator OBF-1\/OCA-B\/Bob1 required for immune response and germinal centre formation. Nature 383, 538\u2013542 (1996).","journal-title":"Nature"},{"key":"314_CR15","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1084\/jem.20042325","volume":"201","author":"LM Corcoran","year":"2005","unstructured":"Corcoran, L. M. et al. Differential requirement for OBF-1 during antibody-secreting cell differentiation. J. Exp. Med. 201, 1385\u20131396 (2005).","journal-title":"J. Exp. Med."},{"key":"314_CR16","doi-asserted-by":"publisher","first-page":"102349","DOI":"10.1016\/j.autrev.2019.102349","volume":"18","author":"H Zhong","year":"2019","unstructured":"Zhong, H., Zhao, C. & Luo, S. HLA in myasthenia gravis: from superficial correlation to underlying mechanism. Autoimmun. Rev. 18, 102349 (2019).","journal-title":"Autoimmun. Rev."},{"key":"314_CR17","first-page":"9518137","volume":"2020","author":"W Jin","year":"2020","unstructured":"Jin, W., Luo, Z. & Yang, H. Peripheral B cell subsets in autoimmune diseases: clinical implications and effects of B cell-targeted therapies. J. Immunol. Res. 2020, 9518137 (2020).","journal-title":"J. Immunol. Res."},{"key":"314_CR18","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1084\/jem.20091548","volume":"207","author":"BC Betz","year":"2010","unstructured":"Betz, B. C. et al. Batf coordinates multiple aspects of B and T cell function required for normal antibody responses. J. Exp. Med. 207, 933\u2013942 (2010).","journal-title":"J. Exp. Med."},{"key":"314_CR19","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.immuni.2019.04.004","volume":"50","author":"SL Stone","year":"2019","unstructured":"Stone, S. L. et al. T-bet transcription factor promotes antibody-secreting cell differentiation by limiting the inflammatory effects of IFN-\u03b3 on B cells. Immunity 50, 1172\u20131187 (2019).","journal-title":"Immunity"},{"key":"314_CR20","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1038\/sj.onc.1201771","volume":"16","author":"ST Ong","year":"1998","unstructured":"Ong, S. T. et al. Lymphadenopathy, splenomegaly, and altered immunoglobulin production in BCL3 transgenic mice. Oncogene 16, 2333\u20132343 (1998).","journal-title":"Oncogene"},{"key":"314_CR21","doi-asserted-by":"publisher","first-page":"25828","DOI":"10.1073\/pnas.1900408116","volume":"116","author":"PE Collins","year":"2019","unstructured":"Collins, P. E. et al. The I\u03baB-protein BCL-3 controls Toll-like receptor-induced MAPK activity by promoting TPL-2 degradation in the nucleus. Proc. Natl Acad. Sci. USA 116, 25828\u201325838 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"314_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/WNL.55.1.16","volume":"55","author":"A Jaretzki 3rd","year":"2000","unstructured":"Jaretzki, A. 3rd et al. Myasthenia gravis: recommendations for clinical research standards. task force of the medical scientific advisory board of the myasthenia gravis foundation of America. Neurology 55, 16\u201323 (2000).","journal-title":"Neurology"},{"key":"314_CR23","doi-asserted-by":"crossref","unstructured":"Garuda, B. R., Vemuri, D., Seepana, G., Sateesh, T. & Aruna Kumari, U. Assessment of disease severity in patients with Myasthenia Gravis \u2013 clinical phenotype and immunological correlation. Neurology https:\/\/n.neurology.org\/content\/92\/15_Supplement\/P5.4-029 (2019).","DOI":"10.1212\/WNL.92.15_supplement.P5.4-029"},{"key":"314_CR24","first-page":"82","volume":"67","author":"A R\u00f8dgaard","year":"1987","unstructured":"R\u00f8dgaard, A., Nielsen, F. C., Djurup, R., Somnier, F. & Gammeltoft, S. Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3. Clin. Exp. Immunol. 67, 82\u201388 (1987).","journal-title":"Clin. Exp. Immunol."},{"key":"314_CR25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","volume":"96","author":"P Narayanaswami","year":"2021","unstructured":"Narayanaswami, P. et al. International consensus guidance for management of myasthenia gravis: 2020 update. Neurology 96, 114\u2013122 (2021).","journal-title":"Neurology"},{"key":"314_CR26","doi-asserted-by":"publisher","first-page":"15137","DOI":"10.1073\/pnas.261570598","volume":"98","author":"AA Lighvani","year":"2001","unstructured":"Lighvani, A. A. et al. T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc. Natl Acad. Sci. USA 98, 15137\u201315142 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"314_CR27","doi-asserted-by":"publisher","first-page":"8137","DOI":"10.1073\/pnas.0600666103","volume":"103","author":"Z Chen","year":"2006","unstructured":"Chen, Z. et al. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl Acad. Sci. USA 103, 8137\u20138142 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"314_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/ni1538","volume":"9","author":"S Kano","year":"2008","unstructured":"Kano, S. et al. The contribution of transcription factor IRF1 to the interferon-gamma-interleukin 12 signaling axis and TH1 versus TH-17 differentiation of CD4+ T cells. Nat. Immunol. 9, 34\u201341 (2008).","journal-title":"Nat. Immunol."},{"key":"314_CR29","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/intimm\/dxs051","volume":"24","author":"CA Wild","year":"2012","unstructured":"Wild, C. A. et al. HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells. Int. Immunol. 24, 485\u2013494 (2012).","journal-title":"Int. Immunol."},{"key":"314_CR30","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/eji.201445064","volume":"45","author":"H Schaffert","year":"2015","unstructured":"Schaffert, H. et al. IL-17-producing CD4(+) T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis. Eur. J. Immunol. 45, 1339\u20131347 (2015).","journal-title":"Eur. J. Immunol."},{"key":"314_CR31","doi-asserted-by":"publisher","first-page":"e826","DOI":"10.1111\/j.1365-2567.2009.03089.x","volume":"128","author":"L Mu","year":"2009","unstructured":"Mu, L. et al. Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis. Immunology 128, e826\u2013e836 (2009).","journal-title":"Immunology"},{"key":"314_CR32","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1038\/sj.emboj.7600133","volume":"23","author":"A Meixner","year":"2004","unstructured":"Meixner, A., Karreth, F., Kenner, L. & Wagner, E. F. JunD regulates lymphocyte proliferation and T helper cell cytokine expression. EMBO J. 23, 1325\u20131335 (2004).","journal-title":"EMBO J."},{"key":"314_CR33","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.4049\/jimmunol.174.4.2061","volume":"174","author":"LA Lyakh","year":"2005","unstructured":"Lyakh, L. A., Sanford, M., Chekol, S., Young, H. A. & Roberts, A. B. TGF-beta and vitamin D3 utilize distinct pathways to suppress IL-12 production and modulate rapid differentiation of human monocytes into CD83+ dendritic cells. J. Immunol. 174, 2061\u20132070 (2005).","journal-title":"J. Immunol."},{"key":"314_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using cellchat. Nat. Commun. 12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"314_CR35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nri3803","volume":"15","author":"S Crotty","year":"2015","unstructured":"Crotty, S. A brief history of T cell help to B cells. Nat. Rev. Immunol. 15, 185\u2013189 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"314_CR36","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/ana.23691","volume":"72","author":"PK Gregersen","year":"2012","unstructured":"Gregersen, P. K. et al. Risk for myasthenia gravis maps to a (151) Proion using CellChat-12 production and modulate rapid diff. Ann. Neurol. 72, 927\u2013935 (2012).","journal-title":"Ann. Neurol."},{"key":"314_CR37","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1001\/jamaneurol.2014.4103","volume":"72","author":"AE Renton","year":"2015","unstructured":"Renton, A. E. et al. A genome-wide association study of myasthenia gravis. JAMA Neurol. 72, 396\u2013404 (2015).","journal-title":"JAMA Neurol."},{"key":"314_CR38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/acn3.51","volume":"1","author":"N Avidan","year":"2014","unstructured":"Avidan, N. et al. VAV1 and BAFF, via NF\u03baB pathway, are genetic risk factors for myasthenia gravis. Ann. Clin. Transl. Neurol. 1, 329\u2013339 (2014).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"314_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.clim.2016.05.003","volume":"166-167","author":"G Saruhan-Direskeneli","year":"2016","unstructured":"Saruhan-Direskeneli, G. et al. Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis. Clin. Immunol. 166-167, 81\u201388 (2016).","journal-title":"Clin. Immunol."},{"key":"314_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3109\/08916939409008008","volume":"19","author":"T Horiki","year":"1994","unstructured":"Horiki, T., Inoko, H., Moriuchi, J., Ichikawa, Y. & Arimori, S. Combinations of HLA-DPB1 and HLA-DQB1 alleles determine susceptibility to early-onset myasthenia gravis in Japan. Autoimmunity 19, 49\u201354 (1994).","journal-title":"Autoimmunity"},{"key":"314_CR41","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/sj.gene.6364110","volume":"5","author":"M Giraud","year":"2004","unstructured":"Giraud, M. et al. Genetic control of autoantibody expression in autoimmune myasthenia gravis: role of the self-antigen and of HLA-linked loci. Genes Immun. 5, 398\u2013404 (2004).","journal-title":"Genes Immun."},{"key":"314_CR42","doi-asserted-by":"publisher","first-page":"4668","DOI":"10.1073\/pnas.91.11.4668","volume":"91","author":"HJ Garchon","year":"1994","unstructured":"Garchon, H. J., Djabiri, F., Viard, J. P., Gajdos, P. & Bach, J. F. Involvement of human muscle acetylcholine receptor alpha-subunit gene (CHRNA) in susceptibility to myasthenia gravis. Proc. Natl Acad. Sci. USA 91, 4668\u20134672 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"314_CR43","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1046\/j.1365-2370.1998.00129.x","volume":"25","author":"G Zelano","year":"1998","unstructured":"Zelano, G. et al. Tumour necrosis factor beta gene polymorphisms in myasthenia gravis. Eur. J. Immunogenet. 25, 403\u2013408 (1998).","journal-title":"Eur. J. Immunogenet."},{"key":"314_CR44","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S0165-5728(97)00161-6","volume":"81","author":"D Huang","year":"1998","unstructured":"Huang, D., Pirskanen, R., Hjelmstr\u00f6m, P. & Lefvert, A. K. Polymorphisms in IL-1beta and IL-1 receptor antagonist genes are associated with myasthenia gravis. J. Neuroimmunol. 81, 76\u201381 (1998).","journal-title":"J. Neuroimmunol."},{"key":"314_CR45","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S0165-5728(01)00449-0","volume":"122","author":"FL Sciacca","year":"2002","unstructured":"Sciacca, F. L. et al. IL-1 genes in myasthenia gravis: IL-1A -889 polymorphism associated with sex and age of disease onset. J. Neuroimmunol. 122, 94\u201399 (2002).","journal-title":"J. Neuroimmunol."},{"key":"314_CR46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jneuroim.2009.02.009","volume":"210","author":"EH Alseth","year":"2009","unstructured":"Alseth, E. H., Nakkestad, H. L., Aarseth, J., Gilhus, N. E. & Skeie, G. O. Interleukin-10 promoter polymorphisms in myasthenia gravis. J. Neuroimmunol. 210, 63\u201366 (2009).","journal-title":"J. Neuroimmunol."},{"key":"314_CR47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10072-015-2375-y","volume":"37","author":"YX Yue","year":"2016","unstructured":"Yue, Y. X. et al. Association study between IL-17A and IL-17F gene polymorphism and myasthenia gravis in Chinese patients. Neurol. Sci. 37, 123\u2013130 (2016).","journal-title":"Neurol. Sci."},{"key":"314_CR48","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1006\/jaut.1997.0140","volume":"10","author":"F Djabiri","year":"1997","unstructured":"Djabiri, F. et al. Association of the AChRalpha-subunit gene (CHRNA), DQA1*0101, and the DR3 haplotype in myasthenia gravis. Evidence for a three-gene disease model in a subgroup of patients. J. Autoimmun. 10, 407\u2013413 (1997).","journal-title":"J. Autoimmun."},{"key":"314_CR49","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1126\/science.1131078","volume":"313","author":"H Schneider","year":"2006","unstructured":"Schneider, H. et al. Reversal of the TCR stop signal by CTLA-4. Science 313, 1972\u20131975 (2006).","journal-title":"Science"},{"key":"314_CR50","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","volume":"31","author":"CE Sutton","year":"2009","unstructured":"Sutton, C. E. et al. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31, 331\u2013341 (2009).","journal-title":"Immunity"},{"key":"314_CR51","doi-asserted-by":"publisher","first-page":"3491269","DOI":"10.1155\/2018\/3491269","volume":"2018","author":"R Shamilov","year":"2018","unstructured":"Shamilov, R. & Aneskievich, B. J. TNIP1 in autoimmune diseases: regulation of toll-like receptor signaling. J. Immunol. Res. 2018, 3491269 (2018).","journal-title":"J. Immunol. Res."},{"key":"314_CR52","first-page":"143","volume":"56","author":"L Quartuccio","year":"2004","unstructured":"Quartuccio, L., Fabris, M. & Ferraccioli, G. B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis. Reumatismo 56, 143\u2013146 (2004).","journal-title":"Reumatismo"},{"key":"314_CR53","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/cmi.2015.61","volume":"14","author":"M You","year":"2017","unstructured":"You, M. et al. Ligation of CD180 inhibits IFN-\u03b1 signaling in a Lyn-PI3K-BTK-dependent manner in B cells. Cell. Mol. Immunol. 14, 192\u2013202 (2017).","journal-title":"Cell. Mol. Immunol."},{"key":"314_CR54","doi-asserted-by":"publisher","first-page":"7043","DOI":"10.4049\/jimmunol.174.11.7043","volume":"174","author":"Y Nagai","year":"2005","unstructured":"Nagai, Y. et al. The radioprotective 105\/MD-1 complex links TLR2 and TLR4\/MD-2 in antibody response to microbial membranes. J. Immunol. 174, 7043\u20137049 (2005).","journal-title":"J. Immunol."},{"key":"314_CR55","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1084\/jem.187.2.185","volume":"187","author":"JH Caama\u00f1o","year":"1998","unstructured":"Caama\u00f1o, J. H. et al. Nuclear factor (NF)-kappa B2 (p100\/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J. Exp. Med. 187, 185\u2013196 (1998).","journal-title":"J. Exp. Med."},{"key":"314_CR56","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/art.39993","volume":"69","author":"MJ Levels","year":"2017","unstructured":"Levels, M. J. et al. The transcriptional coactivator Bob1 is associated with pathologic B cell responses in autoimmune tissue inflammation. Arthritis Rheumatol. 69, 750\u2013762 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"314_CR57","doi-asserted-by":"publisher","first-page":"147","DOI":"10.14785\/lpsn-2015-0005","volume":"2","author":"D Merico","year":"2015","unstructured":"Merico, D., Sharfe, N., Hu, P., Herbrick, J.-A. & Roifman, C. M. RelB deficiency causes combined immunodeficiency. LymphoSign J. 2, 147\u2013155 (2015).","journal-title":"LymphoSign J."},{"key":"314_CR58","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.4049\/jimmunol.1502043","volume":"196","author":"C Ding","year":"2016","unstructured":"Ding, C. et al. STAT3 signaling in B cells is critical for germinal center maintenance and contributes to the pathogenesis of murine models of lupus. J. Immunol. 196, 4477\u20134486 (2016).","journal-title":"J. Immunol."},{"key":"314_CR59","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.1073\/pnas.052247099","volume":"99","author":"DH Wagner Jr.","year":"2002","unstructured":"Wagner, D. H. Jr. et al. Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes. Proc. Natl Acad. Sci. USA 99, 3782\u20133787 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"314_CR60","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/imm.12761","volume":"152","author":"GM Vaitaitis","year":"2017","unstructured":"Vaitaitis, G. M., Waid, D. M., Yussman, M. G. & Wagner, D. H. Jr. CD40-mediated signalling influences trafficking, T-cell receptor expression, and T-cell pathogenesis, in the NOD model of type 1 diabetes. Immunology 152, 243\u2013254 (2017).","journal-title":"Immunology"},{"key":"314_CR61","doi-asserted-by":"publisher","first-page":"6070","DOI":"10.4049\/jimmunol.180.9.6070","volume":"180","author":"X Liu","year":"2008","unstructured":"Liu, X., Lee, Y. S., Yu, C. R. & Egwuagu, C. E. Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases. J. Immunol. 180, 6070\u20136076 (2008).","journal-title":"J. Immunol."},{"key":"314_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17597-3","volume":"7","author":"S Yamazaki","year":"2017","unstructured":"Yamazaki, S. et al. The AP-1 transcription factor JunB is required for Th17 cell differentiation. Sci. Rep. 7, 17402 (2017).","journal-title":"Sci. Rep."},{"key":"314_CR63","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902 (2019). e1821.","journal-title":"Cell"},{"key":"314_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"314_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."},{"key":"314_CR66","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L.-G., Han, Y. & He, Q.-Y. ClusterProfiler: an R package for comparing biological themes among gene clusters. Omics: a J. Integr. Biol. 16, 284\u2013287 (2012).","journal-title":"Omics: a J. Integr. Biol."},{"key":"314_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinforma. 14, 7 (2013).","journal-title":"BMC Bioinforma."},{"key":"314_CR68","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"314_CR69","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"314_CR70","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu, X. et al. Reversed graph embedding resolves complex single-cell trajectories. Nat. Methods 14, 979\u2013982 (2017).","journal-title":"Nat. Methods"},{"key":"314_CR71","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/bioinformatics\/btv715","volume":"32","author":"P Angerer","year":"2016","unstructured":"Angerer, P. et al. Destiny: diffusion maps for large-scale single-cell data in R. Bioinformatics 32, 1241\u20131243 (2016).","journal-title":"Bioinformatics"},{"key":"314_CR72","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41586-018-0414-6","volume":"560","author":"G La Manno","year":"2018","unstructured":"La Manno, G. et al. RNA velocity of single cells. Nature 560, 494\u2013498 (2018).","journal-title":"Nature"}],"container-title":["Cell Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41421-021-00314-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41421-021-00314-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41421-021-00314-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T06:07:47Z","timestamp":1725775667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41421-021-00314-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,14]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["314"],"URL":"https:\/\/doi.org\/10.1038\/s41421-021-00314-w","relation":{},"ISSN":["2056-5968"],"issn-type":[{"value":"2056-5968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,14]]},"assertion":[{"value":"16 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"85"}}